Related Experiment Video

Updated: Aug 18, 2026

Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages
13:47

Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages

Published on: December 11, 2013

A TH1-TH2-like switch in candidiasis: new perspectives for therapy

P Puccetti1, L Romani, F Bistoni

  • 1Dept of Experimental Medicine, University of Rome Tor Vergata, Italy.

Trends in Microbiology
|June 1, 1995
PubMed

Insights

An imbalance between T helper 1 (TH1) and T helper 2 (TH2) immune responses may enable Candida albicans to persist in the host. This immune dysregulation has implications for allergies, autoimmune diseases, and co-infections.

Area of Science:

  • Immunology
  • Microbiology
  • Medical Mycology

Background:

  • The immune system's balance between T helper 1 (TH1) and T helper 2 (TH2) cells is crucial for controlling infections.
  • Candida albicans is an opportunistic fungal pathogen that can cause a range of infections, from superficial to life-threatening.

Purpose of the Study:

  • To investigate the hypothesis that an imbalance in TH1/TH2 responses facilitates Candida albicans persistence.
  • To explore the implications of this immune imbalance for conditions like allergy, autoimmunity, and co-infection.
  • To highlight the potential therapeutic role of cytokine and anti-cytokine treatments in managing Candida-related diseases.

Main Methods:

  • This study is based on a hypothesis and its implications, rather than specific experimental methods.
  • The approach involves analyzing the interplay between host immune responses and fungal persistence.

Main Results:

  • A skewed TH1/TH2 balance may allow Candida albicans to evade immune clearance and establish persistent infections.
  • Such immune dysregulation could contribute to the development or exacerbation of allergic and autoimmune conditions.
  • The findings suggest that manipulating cytokine profiles could be a viable therapeutic strategy.

Conclusions:

  • Immune response imbalance is a key factor in Candida albicans pathogenesis.
  • Targeting cytokines offers a potential therapeutic avenue for Candida-related conditions.
  • Further research into TH1/TH2 modulation is warranted for managing fungal infections and associated pathologies.

More Related Videos

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice08:02

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice

Published on: February 18, 2015

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense06:53

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense

Published on: April 17, 2026

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...